Prof. Dr. Ömer Erol UZEL

Radyasyon Onkolojisi (Radyoterapi)

İSTÜN Şişli Kolan International Hospital

Prof. Dr. Ömer Erol UZEL

Radyasyon Onkolojisi (Radyoterapi)

İSTÜN Şişli Kolan International Hospital

EĞİTİM

  • 1978 – 1984 İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi
  • 1986 – 1990 Uzmanlık- İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi

İLGİ ALANLARI

  • Baş – Boyun Kanserleri
  • Merkezi Sinir Sistemi Tümörü
  • Meme Kanseri
  • Akciğer Kanseri
  • jinekolojik Tümörler
  • Gastrointestinal Kanserler
  • Stereotaktik Radyoterapi (SRS-SBRT)

ÇALIŞTIĞI KURUMLAR

  • 1992 – 2016 İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi
  • 2016 – 2017 Yeni Yüzyıl Üniversitesi
  • 2018 – 2019 Medipol Üniversitesi
  • 2019 – Halen İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi
  • 2025 – Halen Özel Şişli Kolan Internatıonal Hospital

Makalaler;

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

  1. Stereotactic body radiation therapy for stage Imedical y operable non-smal cel lung cancer KocakUzelE.,BAĞCIM.,MorcaliH.,UZELÖ.E. ScientificReports, cilt.13, sa.1,2023 (SCI-Expanded)

II . Selective local postoperative radiotherapy for T3-T4 N0 laryngeal cancer DAĞDELENM.,SahinM.,KURTÇATAL T.,YILDIRIMH.C.,KARAÇAMS.,ÇEPNİK.,UZELÖ.E. STRAHLENTHERAPIEUNDONKOLOGIE, cilt.198, sa.11, ss.1025-1031,2022 (SCI-Expanded)

 III. Nasopharyngeal Carcinoma in Children and Adolescents: Result of Patients Treated with 61,2-63 Gy DagdelenM.,KanatS.,CatalT.K.,YildirmH.,AkovaliE.S.,KaracamS.C.,UZELÖ.E. RADIOTHERAPYANDONCOLOGY, cilt.170,2022 (SCI-Expanded)

  1. Episcleral Iodine-125 radioactive plaque brachytherapy as a salvage treatment for retinoblastoma in the era of intraarterial chemotherapy. SarıcıA.M.,CelkanT.T.,BatuOtoB.,ŞahinA.,UzelÖ.E.,UçarD. TheTurkish journalofpediatrics, cilt.64, sa.2, ss.285-292,2022 (SCI-Expanded)
  2. Is Single Cord Irradiation Going to Be a NewStandard for T1a Glottic Carcinoma? KocakUzelE.,FigenM.,UZELÖ.E. FRONTIERS INONCOLOGY, cilt.10,2020 (SCI-Expanded)
  3. Total-body irradiation using linac-based volumetricmodulated arc therapy: Its clinical accuracy, feasibility and reliability TasB.,Durmus I.F.,OkumusA.,UzelÖ.E.,GokceM.,GoksoyH.S.,OzsahinE.M. RADIOTHERAPYANDONCOLOGY, cilt.129, sa.3, ss.527-533,2018 (SCI-Expanded)

 VI . Relationship between survival and increased radiation dose to subventricular zone in glioblastoma is controversial. ElicinO., InacE.,UzelE.K.,KaracamS.,UzelÖ.E. Journalofneuro-oncology, cilt.118, sa.2, ss.413-419,2014 (SCI-Expanded)

 VII. Human papil omavirus is independent prognostic factor on outcome of oropharyngeal squamous cel carcinoma. TuralD.,ElicinO.,Batur S.,ArslanD.,OzB.,SerdengectiS.,UzelÖ.E. Tumour biology : the journalof the InternationalSociety forOncodevelopmentalBiology andMedicine, cilt.34, sa.6, ss.3363-9,2013 (SCI-Expanded)

  1. Comparison of two different IMRT planning techniques in the treatment of nasopharyngeal carcinoma. Effect on parotid gland radiation doses. UzelE.K.,KaracamS.,ElicinO.,UzelÖ.E. Strahlentherapie undOnkologie :OrganderDeutschenRontgengesel schaft . [etal], cilt.189, sa.7, ss.552-8,2013 (SCI-Expanded)
  2. Increase in the rate of HPV positive oropharyngeal cancers during 1996-2011 in a case study in Turkey. TuralD.,ElicinO.,Batur S.,ArslanD.,OzB.,SerdengectiS.,UzelÖ.E. AsianPacific journalof cancer prevention:APJCP, cilt.14, sa.10, ss.6065-8,2013 (SCI-Expanded)
  3. Is FDG -PET-CT a valuable tool in prediction of persistent disease in head and neck cancer. UzelE.K.,EkmekciogluO.,ElicinO.,HalacM.,UzelÖ.E. AsianPacific journalof cancer prevention:APJCP, cilt.14, sa.8, ss.4847-51,2013 (SCI-Expanded)

 XI . Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N35modulesCengizM.,ÖZYARE.,EsassolakM.,AltunM.,AkmansuM.,ŞENM.,UzelÖ.E.,YavuzA.,DalmazG.,UzalC.,etal. INTERNATIONAL JOURNALOFRADIATIONONCOLOGYBIOLOGYPHYSICS, cilt.63, sa.5, ss.1347-1353,2005 (SCIExpanded)

 Diğer Dergilerde Yayınlanan Makaleler

  1. Radiotherapy Outcomes in Adults with H3K27M- Altered Midline Gliomas and Poor Performance Status UZEL E.K.,KILIÇM.B.,FİGENM.,BÖLÜKBAŞM.K.,UZELÖ. Comprehensivemedicine, cilt.16, sa.1, ss.8-12,2024 (HakemliDergi)

II . Clinical Results of Combined Systemic Steroid and Retroorbital Radiotherapy Treatment in Active Thyroid Associated Ophthalmopathy OtoB.,ÇOLPANÖKSÜZD., sert s.,UZELÖ.E.,SariciA.M. DicleTıpDergisi, cilt.50, sa.2, ss.149-155,2023 (HakemliDergi)

III. Evaluation of Anxiety and Depression Scores in Patients Receiving Radiotherapy During FirstWave of COVID-19 Pandemic DağdelenM.,Demir E.,ErgenŞ.A.,DemirelÖ.F.,YıldırımC.,UzelÖ.E.,Şahinler İ.,DinçbaşH.F.Ö.,ÇolpanÖksüzD. CerrahpaşaMedical Journal, cilt.46, sa.2, ss.164-167,2022 (HakemliDergi)

  1. Acantholytic squamous cel carcinoma of larynx as an uncommon variant of squamous cel carcinoma Skuamöz hücreli kanserin nadir bir varyantı olarak larenks akantolitik skuamöz hücreli kanseri TIKENE.E.,ÇolpanÖ.,BATURS.,UZEL E.,ÖzB.,ÖZ F.,UZELÖ.E.,TURKANS. Kulakburunbogaz ihtisasdergisi :KBB=Journalof ear,nose,and throat, cilt.26, sa.3, ss.176-180,2016 (Scopus)
  2. Acute toxicity in nasopharyngeal carcinoma patients treated with IMRT/VMAT Ozdemir S.,AkinM.,CobanY.,YildirimC.,UzelÖ.E. AsianPacific JournalofCancer Prevention, cilt.16, sa.5, ss.1897-1900,2015 (Scopus)
  3. Olfactory neuroblastomas: an experience of 24 years. TuralD.,YildizO.,SelcukbiricikF.,OzturkM.A.,KelesY.,OzB.,UzelÖ.E.,DemirG.,MandelN.M. ISRNoncology, cilt.2011, ss.451086,2011

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler

  1. Re- Irradiation for Local y Recurrent Nasopharyngeal Carcinoma: treatment Results and Prognostic Factors.Ecco ÇOLPANÖKSÜZD.,MeralG.,UZELÖ.E.,TURKANT.S.,ÇAĞATAYP. 12 theEuropeanConference.,Danimarka, ss.1, (ÖzetBildiri)

II . Comparison of different treatmentmethods in craniospinal radiotherapy. TikenE.E.,CobanY.,AkinM.,KaracamS.,UzelÖ.E.,TurkanT.S. 50thAnnualMeeting of theAmerican-Society-of-Clinical-Oncology, Il inois,AmerikaBirleşikDevletleri,30Mayıs – 03Haziran2014, cilt.32, (ÖzetBildiri)

III. Dosimetric evaluation of nasopharyngeal carcinomas irradiated with different IMRT techniques Ozdemir S.,CobanY.,AkinM.,AmbarciogluP.,OnayO.,KaracamS.,UzelE.K.,UzelO. EuropeanCancer Congress2013 -17thECCO/ 38thESMO/ 32ndESTRO,Amsterdam,Holanda,27Eylül -01 Ekim2013, cilt.49, (ÖzetBildiri)

  1. To Compare Effect of Two Different IMRT Planning Techniques on Parotid Doses in PatientsWith Nasopharyngeal Carcinoma KocakE.,UzelO.,KaracamS. EuropeanMultidisciplinaryCancer Congress onIntegratingBasic andTranslationalScience,Surgery, Radiotherapy,Medicaloncology,Advocacy andCare,Stockholm, İsveç,23 -27Eylül2011, cilt.47, (ÖzetBildiri)
  2. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: A rare cancer network study Ozyar E.,SelekU.,Laskar S.,UzelO.,AnacakY.,Ben-ArushM.,Polychronopoulou S.,AkmanF.,WoldenS.,SarihanS., etal. 47thAnnualMeeting of theAmerican-Society-for-Therapeutic-Radiology-and-Oncology,Colorado,AmerikaBirleşik Devletleri,16 -20Ekim2005, cilt.63, (ÖzetBildiri)
  3. Assessment of quality life of nasopharyngeal carcinoma patients with EORTC QLQ C30 and H&N 30: Turkish oncology group, head and neckworking party study CengizM.,Ozyar E.,EsassolakM.,AltunM.,AkmansuM.,SenM.,UzelO.,YavuzA.,DalmazG.,UzalC.,etal. 46thAnnualMeeting of theAmerican-Society-for-Therapeutic-Radiology-and-Oncology,Georgia,AmerikaBirleşik Devletleri,3 -07Ekim2004, cilt.60, (ÖzetBildiri)

VII .  Re- Irradiation for Local y Recurrent Nasopharyngeal Carcinoma: treatment Results and Prognostic Factors.Ecco ÇOLPANÖKSÜZD.,MeralG.,UZELÖ.E.,TURKANT.S.,ÇAĞATAYP. 12 theEuropeanConference.,Copenhagen,Danimarka,21 -25Eylül2003, ss.2, (ÖzetBildiri)

Henüz yazı bulunamadı.
hizliRandevu